Physician profile
Ali A Sovari
NPI 1184823494
$55,494.85
in general payments reported to CMS, 2019-2025
34 companies · $7,871 in 2025
The $7,871 reported for 2025 was more than what 75% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,182 · 2020: $5,236 · 2021: $3,406 · 2022: $9,825 · 2023: $11K · 2024: $12K · 2025: $7,871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,500 · Travel and Lodging: $7,098 · Consulting Fee: $2,657 · Education: $7.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,581.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,500.00 |
| Travel and Lodging | $7,098.26 |
| Consulting Fee | $2,657.00 |
| Education | $7.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17,480.52 | 2019-2025 | Lifevest |
| Medtronic, INC. | $12,915.51 | 2021-2025 | Micra, Affera Mapping System, Arctic Front Advance |
| Boston Scientific Corporation | $11,247.52 | 2019-2025 | Rhythmia Mapping System, Farapulse, Watchman Flx |
| Abbott Laboratories | $8,174.11 | 2019-2025 | Aveir, Na, Amplatzer Amulet |
| Biosense Webster, INC. | $1,263.41 | 2019-2024 | Thermocool Sf, Carto 3 |
| Medtronic Vascular, INC. | $751.75 | 2019-2020 | |
| Cardiva Medical, INC. | $556.53 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cook Medical LLC | $491.95 | 2019-2023 | Evolution |
| Novartis Pharmaceuticals Corporation | $299.03 | 2019-2023 | |
| Atricure, INC. | $267.56 | 2019-2021 | |
| Abiomed | $254.93 | 2025 | |
| Impulse Dynamics (USA) INC. | $237.45 | 2023-2024 | Optimizer, Optimizer |
| Ebr Systems, INC. | $197.78 | 2025 | |
| Bardy Diagnostics, INC. | $179.31 | 2021-2022 | |
| Cvrx, INC. | $167.01 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $123.90 | 2019-2023 | Wainua |
| Sanofi-Aventis U.S. LLC | $104.84 | 2019-2023 | |
| Pfizer INC. | $96.88 | 2020-2025 | |
| Amgen INC. | $89.91 | 2019 | |
| W. L. Gore & Associates, INC. | $81.94 | 2025 | Gore Cardioform Septal Occluder |
| Baxter Healthcare | $76.87 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Merit Medical Systems INC | $65.01 | 2025 | |
| Heartflow, INC. | $64.00 | 2023-2025 | Ffrct |
| Actelion Pharmaceuticals US, INC. | $44.81 | 2022-2023 | Uptravi, Opsumit |
| Altathera Pharmaceuticals LLC | $43.62 | 2024-2025 | Sotalol Hydrochloride |
| Janssen Pharmaceuticals, INC | $36.63 | 2019 | |
| Irhythm Technologies, INC. | $36.33 | 2023 | Zio Xt Patch |
| Amarin Pharma, INC. | $30.97 | 2019 | |
| Cordis US Corp. | $30.49 | 2025 | Mynx Control Venous |
| Angiodynamics, INC. | $19.54 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.10 | 2023 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $17.92 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $14.43 | 2019 | |
| Philips North America LLC | $14.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Sovari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.